| Dr James Andrew Botros, MD | |
|
2211 Lomas Blvd Ne, Albuquerque, NM 87106 | |
| (505) 272-3401 | |
| Not Available |
| Full Name | Dr James Andrew Botros |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 14 Years |
| Location | 2211 Lomas Blvd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326365263 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD2018-0697 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of New Mexico Hospital | Albuquerque, NM | Hospital |
| Lovelace Medical Center | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Vincent Hospital | 6608775135 | 267 |
| University Of New Mexico Medical Group | 4981795267 | 1002 |
News Archive
Individuals with higher education levels appear to score higher on cognitive tests despite having evidence of brain plaques associated with Alzheimer's disease, according to a report in the November issue of Archives of Neurology , one of the JAMA/Archives journals.
Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
A team of European scientists from the University Medical Center Hamburg-Eppendorf and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases at the University of Cologne in Germany has taken an important step closer to understanding the root cause of age-related dementia.
› Verified 8 days ago
| Entity Name | St. Vincent Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578587150 PECOS PAC ID: 6608775135 Enrollment ID: O20040105000372 |
News Archive
Individuals with higher education levels appear to score higher on cognitive tests despite having evidence of brain plaques associated with Alzheimer's disease, according to a report in the November issue of Archives of Neurology , one of the JAMA/Archives journals.
Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
A team of European scientists from the University Medical Center Hamburg-Eppendorf and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases at the University of Cologne in Germany has taken an important step closer to understanding the root cause of age-related dementia.
› Verified 8 days ago
| Entity Name | Taos Health Systems Inc Holy Cross Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194751958 PECOS PAC ID: 8224937412 Enrollment ID: O20040107000398 |
News Archive
Individuals with higher education levels appear to score higher on cognitive tests despite having evidence of brain plaques associated with Alzheimer's disease, according to a report in the November issue of Archives of Neurology , one of the JAMA/Archives journals.
Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
A team of European scientists from the University Medical Center Hamburg-Eppendorf and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases at the University of Cologne in Germany has taken an important step closer to understanding the root cause of age-related dementia.
› Verified 8 days ago
| Entity Name | Otero County Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861450579 PECOS PAC ID: 3173516606 Enrollment ID: O20070212000377 |
News Archive
Individuals with higher education levels appear to score higher on cognitive tests despite having evidence of brain plaques associated with Alzheimer's disease, according to a report in the November issue of Archives of Neurology , one of the JAMA/Archives journals.
Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
A team of European scientists from the University Medical Center Hamburg-Eppendorf and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases at the University of Cologne in Germany has taken an important step closer to understanding the root cause of age-related dementia.
› Verified 8 days ago
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
Individuals with higher education levels appear to score higher on cognitive tests despite having evidence of brain plaques associated with Alzheimer's disease, according to a report in the November issue of Archives of Neurology , one of the JAMA/Archives journals.
Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
A team of European scientists from the University Medical Center Hamburg-Eppendorf and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases at the University of Cologne in Germany has taken an important step closer to understanding the root cause of age-related dementia.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Andrew Botros, MD 1 University Of New Mexico Msc 10-5615, Albuquerque, NM 87131-0001 Ph: (505) 272-3401 | Dr James Andrew Botros, MD 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Ph: (505) 272-3401 |
News Archive
Individuals with higher education levels appear to score higher on cognitive tests despite having evidence of brain plaques associated with Alzheimer's disease, according to a report in the November issue of Archives of Neurology , one of the JAMA/Archives journals.
Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
ImmunoGen, Inc., a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced the presentation of new clinical data with the Company's targeted anticancer compound, IMGN901.
A team of European scientists from the University Medical Center Hamburg-Eppendorf and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases at the University of Cologne in Germany has taken an important step closer to understanding the root cause of age-related dementia.
› Verified 8 days ago
Dr. Gerald Nathan Gold, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1509 Harvard Ct Ne, Albuquerque, NM 87106 Phone: 505-255-0555 | |
Mehrnoush Gorjian, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: Department Of Neurosurgery 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4280 | |
Sheila Rose Eshraghi, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1 University Of New Mexico, Msc10 5615, Albuquerque, NM 87131 Phone: 505-272-3401 | |
Daniel Shibuya, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Walter St Ne, Ste 401, Albuquerque, NM 87102 Phone: 505-727-5910 Fax: 505-727-5939 | |
Paul Turner, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 5-north University Hospital, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-3160 | |
Dr. Chad Douglas Cole, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-0621 |